Skip to main content

and
  1. Article

    Open Access

    Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway

    Cell-based therapy represents a new frontier in the treatment of a wide variety of human diseases traditionally associated with morbidity outcomes, including those involving inflammation, autoimmunity, tissue ...

    Ikiru Atsuta, Shiyu Liu, Yasuo Miura, Kentaro Akiyama in Stem Cell Research & Therapy (2013)